Idiopathic Non-Cirrhotic Intrahepatic Portal Hypertension (NCIPH)-Newer Insights into Pathogenesis and Emerging Newer Treatment Options.

PubWeight™: 0.84‹?›

🔗 View Article (PMC 4284211)

Published in J Clin Exp Hepatol on July 28, 2014

Authors

Ashish Goel1, Joshua E Elias2, Chundamannil E Eapen1, Banumathi Ramakrishna3, Elwyn Elias4

Author Affiliations

1: Department of Hepatology, Christian Medical College, Vellore, Tamil Nadu, India.
2: Addenbrooke's Hospital, Cambridge, UK.
3: Department of Pathology, Christian Medical College, Vellore, Tamil Nadu, India.
4: Department of Hepatology, Christian Medical College, Vellore, Tamil Nadu, India ; Liver Unit, University Hospital Birmingham, Birmingham, UK.

Articles cited by this

Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol (2010) 5.78

Non-cirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature. J Gastroenterol Hepatol (2002) 2.43

Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology (1990) 2.32

Extra- and intrahepatic portal hypertension without cirrhosis (hepatoportal sclerosis). Ann Surg (1965) 2.10

Idiopathic noncirrhotic portal hypertension. Hepatology (2011) 2.05

Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow. Blood (2004) 1.90

Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV. Am J Gastroenterol (2007) 1.77

Hepatic manifestations in chronic arsenic toxicity. Indian J Gastroenterol (1999) 1.72

Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1 expression: implications for the pathogenesis of HIV/hepatitis C virus-induced liver fibrosis. Hepatology (2010) 1.72

Nodular regenerative hyperplasia of the liver in hematologic disorders: a possible response to obliterative portal venopathy. A morphometric study of nine cases with an hypothesis on the pathogenesis. Medicine (Baltimore) (1980) 1.71

Platelet transfusion during liver transplantation is associated with increased postoperative mortality due to acute lung injury. Anesth Analg (2009) 1.70

Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients. Gut (2002) 1.68

Incomplete septal cirrhosis: histopathological aspects. Histopathology (1988) 1.63

Hepatocellular carcinoma and nodular regenerative hyperplasia: possible pathogenetic relationship. Am J Gastroenterol (1996) 1.62

Chronic oral arsenic intoxication as a possible aetiological factor in idiopathic portal hypertension (non-cirrhotic portal fibrosis) in India. Gut (1979) 1.58

Noncirrhotic portal fibrosis. Am J Med (1971) 1.52

Idiopathic portal hypertension. Comparison with the portal hypertension of cirrhosis and extrahepatic portal vein obstruction. Ann Intern Med (1967) 1.51

Idiopathic noncirrhotic portal hypertension is associated with poor survival: results of a long-term cohort study. Aliment Pharmacol Ther (2012) 1.49

Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis. Histopathology (2010) 1.48

Clinical study of eighty-six cases of idiopathic portal hypertension and comparison with cirrhosis with splenomegaly. Gastroenterology (1984) 1.43

Prophylactic surgery in non-cirrhotic portal fibrosis:is it worthwhile? Indian J Gastroenterol (2006) 1.41

Significance of nodular regenerative hyperplasia occurring de novo following liver transplantation. Liver Transpl (2007) 1.39

Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities. J Hepatol (2007) 1.31

Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment. Hepatol Int (2007) 1.24

Tissue distribution of factor VIII gene expression in vivo--a closer look. Thromb Haemost (2001) 1.24

Non-cirrhotic intrahepatic portal hypertension: associated gut diseases and prognostic factors. Dig Dis Sci (2010) 1.21

Histopathology of the liver in non-cirrhotic portal hypertension of unknown aetiology. Histopathology (1996) 1.17

Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome. Antivir Ther (2008) 1.12

Idiopathic noncirrhotic intrahepatic portal hypertension is associated with sustained ADAMTS13 Deficiency. Dig Dis Sci (2011) 1.11

Hepatic vascular disease and portal hypertension in polycythemia vera and agnogenic myeloid metaplasia: a clinicopathological study of 145 patients examined at autopsy. Hepatology (1990) 1.11

Liver pathology of idiopathic portal hypertension. Comparison with non-cirrhotic portal fibrosis of India. The Japan idiopathic portal hypertension study. Liver (1982) 1.09

Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency. Clin Gastroenterol Hepatol (2013) 1.09

Nodular regenerative hyperplasia in common variable immunodeficiency. J Clin Immunol (2013) 1.09

Measurement and correlation of wedged hepatic, intrahepatic, intrasplenic and intravariceal pressures in patients with cirrhosis of liver and non-cirrhotic portal fibrosis. Gut (1987) 1.08

Non-cirrhotic portal fibrosis with portal hypertension: a new syndrome. I. Clinical and function studies and results of operations. Indian J Med Res (1967) 1.08

Clinicopathological features of nine cases of non-cirrhotic portal hypertension: current definitions and criteria are inadequate. Histopathology (2003) 1.05

Pathology and pathogenesis of idiopathic portal hypertension with an emphasis on the liver. Pathol Res Pract (2001) 1.04

Acquired protein S deficiency leads to obliterative portal venopathy and to compensatory nodular regenerative hyperplasia in HIV-infected patients. AIDS (2009) 1.03

Liver transplantation for severe intrahepatic noncirrhotic portal hypertension. Liver Transpl (2005) 1.02

Studies on capillarization of the hepatic sinusoids in alcoholic liver disease. Alcohol Alcohol Suppl (1993) 1.01

Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings. AIDS (2010) 0.99

Role of Tc99m sulfur colloid scintigraphy in differentiating non-cirrhotic portal fibrosis from cirrhosis liver. Indian J Nucl Med (2010) 0.99

Non-specific immunological abnormalities and association of autoimmune diseases in idiopathic portal hypertension. A study by questionnaire. Hepatogastroenterology (1993) 0.99

Serum cytokine elevations in celiac disease: association with disease presentation. Hum Immunol (2010) 0.99

Histopathology of portal hypertension: a practical guideline. Histopathology (2003) 0.98

The role of nucleoside and nucleotide analogues in nodular regenerative hyperplasia in HIV-infected patients: a case control study. J Hepatol (2010) 0.95

Overlap of idiopathic portal hypertension and scleroderma: report of two autopsy cases and a review of literature. J Gastroenterol Hepatol (2002) 0.95

Obliterative portal venopathy: portal hypertension is not always present at diagnosis. J Hepatol (2010) 0.94

Non-cirrhotic portal hypertension in HIV-infected individuals. Int J STD AIDS (2011) 0.93

Idiopathic portal hypertension in patients with HIV infection treated with highly active antiretroviral therapy. Am J Gastroenterol (2009) 0.93

Idiopathic non-cirrhotic intrahepatic portal hypertension: common cause of cryptogenic intrahepatic portal hypertension in a Southern Indian tertiary hospital. Indian J Gastroenterol (2009) 0.93

Familial aggregation in noncirrhotic portal fibrosis: a report of four families. Am J Gastroenterol (1987) 0.90

"Idiopathic" portal hypertension due to occlusion of intrahepatic portal veins by organized thrombi. A study based on postmortem vinylite-injection corrosion and dissection of the intrahepatic vasculature in 4 cases. Medicine (Baltimore) (1974) 0.89

Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy. Am J Surg Pathol (2006) 0.88

Progression from idiopathic portal hypertension to incomplete septal cirrhosis with liver failure requiring liver transplantation. J Hepatol (1995) 0.87

Familial idiopathic pulmonary fibrosis in association with bone marrow hypoplasia and hepatic nodular regenerative hyperplasia: a new "trimorphic" syndrome. Thorax (2009) 0.87

Pivotal role of ADAMTS13 function in liver diseases. Int J Hematol (2010) 0.87

Intrahepatic portal venopathy and related disorders of the liver. Semin Liver Dis (2008) 0.87

Nodular regenerative hyperplasia of the liver and coeliac disease: potential role of IgA anticardiolipin antibody. Gut (2004) 0.86

Increased incidence of glomerulonephritis following spleno-renal shunt surgery in non-cirrhotic portal fibrosis. Kidney Int (1997) 0.85

Incidence of nodular regenerative hyperplasia in inflammatory bowel disease patients treated with azathioprine. Inflamm Bowel Dis (2011) 0.85

Review article: the association between nodular regenerative hyperplasia, inflammatory bowel disease and thiopurine therapy. Aliment Pharmacol Ther (2013) 0.84

Results of liver transplantation for nodular regenerative hyperplasia. Am Surg (2000) 0.84

Non-cirrhotic portal fibrosis: one disease with many names? An analysis from morphological study of native explant livers with end stage chronic liver disease. J Clin Pathol (2011) 0.82

Pulmonary platelet aggregates: possible cause of sudden peroperative death in adults undergoing liver transplantation. J Clin Pathol (1993) 0.82

Didanosine Exposure and Noncirrhotic Portal Hypertension in a HIV Clinic in North America: a Follow-up Study. Br J Med Med Res (2011) 0.80

Aetiology of paediatric portal hypertension - experience of a tertiary care centre in South India. Trop Doct (2009) 0.80

Oesophageal variceal bleeding in Felty's syndrome associated with nodular regenerative hyperplasia. Ann Rheum Dis (1978) 0.80

Nodular regenerative hyperplasia (NRH) complicating oxaliplatin chemotherapy in patients undergoing resection of colorectal liver metastases. Eur J Surg Oncol (2013) 0.80

Role of endothelial-mesenchymal transition in idiopathic portal hypertension. Histol Histopathol (2013) 0.78

Nodular regenerative hyperplasia related portal hypertension in a patient with hypogammaglobulinaemia. World J Gastroenterol (2013) 0.78

Equal efficacy of endoscopic variceal ligation and propranolol in preventing variceal bleeding in patients with noncirrhotic portal hypertension. Gastroenterology (2010) 0.78

Use of serum vitamin B12 level as a marker to differentiate idiopathic noncirrhotic intrahepatic portal hypertension from cryptogenic cirrhosis. Dig Dis Sci (2012) 0.78

Non-cirrhotic intrahepatic portal hypertension. Gut (2008) 0.78

A case of idiopathic portal hypertension associated with rheumatoid arthritis. Mod Rheumatol (2006) 0.78

Nodular regenerative hyperplasia of the liver associated with primary pulmonary hypertension. Hum Pathol (1988) 0.77

ADAMTS13 deficiency, despite well-compensated liver functions in patients with noncirrhotic portal hypertension. Indian J Gastroenterol (2014) 0.77

A study of aetiology of portal hypertension in adults (including the elderly) at a tertiary centre in southern India. Indian J Med Res (2013) 0.77

Idiopathic noncirrhotic intrahepatic portal hypertension is an ongoing problem in India. Hepatology (2011) 0.77

Spectrum of idiopathic noncirrhotic portal hypertension. J Clin Exp Hepatol (2011) 0.77

Porto-pulmonary hypertension exacerbated by platelet transfusion in a patient with ADAMTS13 deficiency. J Hepatol (2012) 0.76

Liver disease in twins with Felty's syndrome. Ann Rheum Dis (1994) 0.76